129 related articles for article (PubMed ID: 9520512)
1. Left ventricular hypertrophy in hypertension: etiology, treatment, and controversies.
Phillips RA; Diamond JA; Gharavi A
Mt Sinai J Med; 1998 Mar; 65(2):97-103. PubMed ID: 9520512
[No Abstract] [Full Text] [Related]
2. [Regression of left ventricular hypertrophy in hypertensive patients].
Bosa Ojeda F; García González M; Domínguez Rodríguez A; Barragán Acea A; Miralles Ibarra JM; Lacalzada Almeida J; de Armas Trujillo D
Rev Esp Cardiol; 1997; 50 Suppl 4():74-6. PubMed ID: 9411592
[TBL] [Abstract][Full Text] [Related]
3. [Left ventricular hypertrophy regression in arterial hypertension. The efficacy of the angiotensin II type 1 receptor antagonists].
González-Juanatey JR; Vallés Belsué F
Med Clin (Barc); 2000; 114 Suppl 1():39-42. PubMed ID: 10812574
[No Abstract] [Full Text] [Related]
4. Left-ventricular hypertrophy and coronary artery disease.
Pierdomenico SD
Am J Hypertens; 2007 Oct; 20(10):1036-7. PubMed ID: 17903684
[No Abstract] [Full Text] [Related]
5. [The hypertensive heart (cardiac hypertension) and secondary drug prophylaxis].
Metelitsa VI
Ter Arkh; 1992; 64(9):112-6. PubMed ID: 1481146
[No Abstract] [Full Text] [Related]
6. Role of aldosterone in left ventricular hypertrophy in hypertension.
Matsumura K; Fujii K; Oniki H; Oka M; Iida M
Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
[TBL] [Abstract][Full Text] [Related]
7. [Pathophysiology of left ventricular hypertrophy in arterial hypertension].
Vallotton MB; Braconi-Quintaje S; Lang U
Praxis (Bern 1994); 1997 Feb; 86(7):234-7. PubMed ID: 9139339
[TBL] [Abstract][Full Text] [Related]
8. Cardiac consequences of aldosterone excess in human hypertension.
Rossi GP
Am J Hypertens; 2006 Jan; 19(1):10-2. PubMed ID: 16461183
[No Abstract] [Full Text] [Related]
9. [Cardioprotective and cardio-reparative drugs].
Bolaños F
Rev Esp Cardiol; 1997; 50 Suppl 4():53-6. PubMed ID: 9411588
[TBL] [Abstract][Full Text] [Related]
10. [The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension].
Rubattu S; Volpe M; Raman V; Lindpaintner K
Cardiologia; 1997 Jan; 42(1):47-50. PubMed ID: 9118154
[No Abstract] [Full Text] [Related]
11. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
12. [Arterial hypertension and cardiac arrhythmias].
Vester EG
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
[TBL] [Abstract][Full Text] [Related]
13. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with arterial hypertension].
Diadyk AI; Bagriĭ AE; Iarova NF; Shchukina EV
Ter Arkh; 1995; 67(8):65-8. PubMed ID: 7482343
[No Abstract] [Full Text] [Related]
14. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
[TBL] [Abstract][Full Text] [Related]
15. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
16. Hypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications.
Yiu KH; Tse HF
J Hum Hypertens; 2008 Jun; 22(6):380-8. PubMed ID: 18337759
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease: what is the evidence?
Wang AY; Li PK; Lui SF; Sanderson JE
Nephrology (Carlton); 2004 Aug; 9(4):190-7. PubMed ID: 15363049
[TBL] [Abstract][Full Text] [Related]
18. Correlations of left ventricular hypertrophy with cardiovascular mortality.
Sharpe N
Int J Clin Pract Suppl; 2000 May; (110):16-22. PubMed ID: 10912303
[No Abstract] [Full Text] [Related]
19. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
[TBL] [Abstract][Full Text] [Related]
20. [Hypertension and the progression of organ damage].
Morganti A
Ital Heart J; 2000 Jun; 1 Suppl 2():100-3. PubMed ID: 10905136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
